CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943134940
- Phone
- 4154825300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $43,476
- in 2 filings
Net −$43,476. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-07-25 | ROBIN HOWARD W President & CEO | Sale | −33,333 | $29.65 | $988K | 295,326 |
| 2019-07-25 | ROBIN HOWARD W President & CEO | Option exercise · Common Stock | −33,333 | 100,000 | ||
| 2019-07-24 | ROBIN HOWARD W President & CEO | Option exercise | +33,334 | $7.21 | $240K | 328,660 |
| 2019-07-24 | ROBIN HOWARD W President & CEO | Sale | −33,334 | $32.11 | $1.1M | 295,326 |
| 2019-07-24 | ROBIN HOWARD W President & CEO | Option exercise · Common Stock | −33,334 | 132,333 | ||
| 2019-07-23 | ROBIN HOWARD W President & CEO | Option exercise | +33,333 | $7.21 | $240K | 328,659 |
| 2019-07-23 | ROBIN HOWARD W President & CEO | Sale | −33,333 | $32.10 | $1.1M | 295,326 |
| 2019-07-23 | ROBIN HOWARD W President & CEO | Option exercise · Common Stock | −33,333 | 166,667 | ||
| 2019-07-10 | Labrucherie Gil M SVP & Chief Financial Officer | Option exercise | +25,000 | $7.21 | $180K | 152,935 |
| 2019-07-10 | Labrucherie Gil M SVP & Chief Financial Officer | Sale | −25,000 | $34.57 | $864K | 127,935 |
| 2019-07-10 | Labrucherie Gil M SVP & Chief Financial Officer | Option exercise · Stock Option | −25,000 | 25,000 | ||
| 2019-07-08 | Lingnau Lutz Director | Option exercise | +10,000 | $9.24 | $92K | 33,200 |
| 2019-07-08 | Lingnau Lutz Director | Sale | −10,000 | $34.63 | $346K | 23,200 |
| 2019-07-08 | Lingnau Lutz Director | Option exercise · Stock Option | −10,000 | 0 | ||
| 2019-06-17 | Labrucherie Gil M SVP & Chief Financial Officer | Option exercise | +25,000 | $7.21 | $180K | 152,935 |
| 2019-06-17 | Labrucherie Gil M SVP & Chief Financial Officer | Sale | −25,000 | $33.71 | $843K | 127,935 |
| 2019-06-17 | Labrucherie Gil M SVP & Chief Financial Officer | Option exercise · Stock Option | −25,000 | 50,000 | ||
| 2019-05-23 | ROBIN HOWARD W President & CEO | Option exercise | +33,333 | $7.21 | $240K | 328,659 |
| 2019-05-23 | ROBIN HOWARD W President & CEO | Sale | −33,333 | $32.69 | $1.1M | 295,326 |
| 2019-05-23 | ROBIN HOWARD W President & CEO | Option exercise · Common Stock | −33,333 | 0 |
Page 25 of 29 · 562 trades